PL370676A1 - 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof - Google Patents

1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof

Info

Publication number
PL370676A1
PL370676A1 PL02370676A PL37067602A PL370676A1 PL 370676 A1 PL370676 A1 PL 370676A1 PL 02370676 A PL02370676 A PL 02370676A PL 37067602 A PL37067602 A PL 37067602A PL 370676 A1 PL370676 A1 PL 370676A1
Authority
PL
Poland
Prior art keywords
diarylprop
ones
compositions containing
containing same
same
Prior art date
Application number
PL02370676A
Other languages
English (en)
Polish (pl)
Inventor
Patrick Mailliet
Cecile Combeau
Marie-Christine Bissery
Marie-Pierre Cherrier
Thomas Caulfield
Gilles Tiraboschi
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0115739A external-priority patent/FR2833008B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of PL370676A1 publication Critical patent/PL370676A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32—N-nitroguanidines
    • C07C279/36—Substituted N-nitroguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
PL02370676A 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof PL370676A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0115739A FR2833008B1 (fr) 2001-12-05 2001-12-05 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR0214217 2002-11-14

Publications (1)

Publication Number Publication Date
PL370676A1 true PL370676A1 (en) 2005-05-30

Family

ID=26213287

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370676A PL370676A1 (en) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof

Country Status (23)

Country Link
EP (1) EP1453790A2 (fr)
JP (1) JP2005531494A (fr)
KR (1) KR20050044712A (fr)
CN (1) CN1612856A (fr)
AR (1) AR037479A1 (fr)
AU (1) AU2002365644A1 (fr)
BR (1) BR0214694A (fr)
CA (1) CA2469193A1 (fr)
CO (1) CO5580759A2 (fr)
EA (1) EA006803B1 (fr)
HR (1) HRP20040508A2 (fr)
HU (1) HUP0500100A2 (fr)
IL (1) IL162223A0 (fr)
MA (1) MA27351A1 (fr)
MX (1) MXPA04005226A (fr)
NZ (1) NZ533224A (fr)
PA (1) PA8558501A1 (fr)
PE (1) PE20030758A1 (fr)
PL (1) PL370676A1 (fr)
RS (1) RS47804A (fr)
SV (1) SV2003001422A (fr)
TW (1) TW200300685A (fr)
WO (1) WO2003048106A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854399B1 (fr) * 2003-04-30 2006-11-17 Aventis Pharma Sa 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation
EP1598353A1 (fr) 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolones et leur utilisation en tant qu'agents antiproliferatifs
WO2017103637A1 (fr) 2015-12-18 2017-06-22 Blirt S.A. Composés de diphénylpropane et leur activité cytotoxique
CN109467549B (zh) * 2018-12-07 2021-02-09 中国药科大学 喹啉取代查尔酮类化合物、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
JPH08277242A (ja) * 1995-02-08 1996-10-22 Kyowa Hakko Kogyo Co Ltd プロペノン誘導体
CN1172476A (zh) * 1995-12-01 1998-02-04 协和发酵工业株式会社 丙烯酮衍生物
EP0996432A2 (fr) * 1997-06-26 2000-05-03 Statens Seruminstitut 1,3-bis-aromatique-prop-2-en-1-ones, 1,3-bis-aromatique-propane-1-ones et 1,3-bis-aromatique-prop-2-yn-1-ones a action biologique

Also Published As

Publication number Publication date
MA27351A1 (fr) 2005-06-01
HRP20040508A2 (en) 2005-08-31
NZ533224A (en) 2006-03-31
IL162223A0 (en) 2005-11-20
HUP0500100A2 (hu) 2005-05-30
CN1612856A (zh) 2005-05-04
WO2003048106A3 (fr) 2004-03-25
MXPA04005226A (es) 2004-10-11
JP2005531494A (ja) 2005-10-20
PE20030758A1 (es) 2003-10-07
PA8558501A1 (es) 2003-09-05
EP1453790A2 (fr) 2004-09-08
WO2003048106A2 (fr) 2003-06-12
AR037479A1 (es) 2004-11-10
AU2002365644A1 (en) 2003-06-17
TW200300685A (en) 2003-06-16
EA006803B1 (ru) 2006-04-28
KR20050044712A (ko) 2005-05-12
CO5580759A2 (es) 2005-11-30
EA200400764A1 (ru) 2004-12-30
BR0214694A (pt) 2004-12-14
SV2003001422A (es) 2003-07-10
CA2469193A1 (fr) 2003-06-12
RS47804A (en) 2006-12-15

Similar Documents

Publication Publication Date Title
HUP0301745A3 (en) Cyclopentanoindoles, compositions containing such compounds and their use
HUP0303825A3 (en) 1h-benzimidazole and 3h-imidazo-[4,5b]pyridine-derivatives, their use and pharmaceutical compositions containing them
EP1426027A4 (fr) Composition et preparation cosmetique contenant ladite composition
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
IL155071A0 (en) Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
IL173299A (en) 2,4-Pyrimidindiamine derivatives, preparations containing them and their use
HUP0301573A3 (en) Substituted arylpyrazines, pharmaceutical compositions containing them and their use
HK1068555A1 (en) New formulations and use thereof
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
IL195166A0 (en) Interferons, uses and compositions related thereto
HUP0400967A3 (en) Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
GB0026467D0 (en) Compound, composition and use
IL162083A0 (en) Catheter composition and uses thereof
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
HK1066022A1 (en) Use of 1,1,1,3,3-pentafluorobutan
EP1390074A4 (fr) Nouvelles compositions et leurs utilisations
HUP0303936A3 (en) Novel composition and use
IL162223A0 (en) 1,3-Diarylprop-2-en-1-ones, compositions containing same and use thereof
GB0005301D0 (en) Compound, composition and use
GB0005299D0 (en) Compound, compositions and use
GB0000131D0 (en) Thiolactomycin analogues,compositions containing the same and uses thereof

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)